Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3302994017 | Parenteral form obinutuzumab (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3302995016 | Parenteral form obinutuzumab | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3488773016 | Product containing obinutuzumab in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3498035010 | Product containing obinutuzumab in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3498036011 | Obinutuzumab in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3711066011 | Obinutuzumab-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3711067019 | Product containing obinutuzumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing obinutuzumab in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing obinutuzumab in parenteral dose form (medicinal product form) | Is a | Product containing obinutuzumab | true | Inferred relationship | Existential restriction modifier | ||
| Product containing obinutuzumab in parenteral dose form (medicinal product form) | Has active ingredient | Obinutuzumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing obinutuzumab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing obinutuzumab in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only obinutuzumab in parenteral dose form (medicinal product form) | Is a | True | Product containing obinutuzumab in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets